2005 Summer Symposium

Past KI Symposia

Understanding Metastasis
June 19, 2009

Nanotechnology and Cancer: The Power of Small Science
June 27, 2008

Systems Biology & Cancer
June 15, 2007

Genomes, Chromosomes, and Cancer
June 23, 2006

The New Science of Cancer Therapy
June 24, 2005

The Small RNA Revolution: Biology, Technology, and Disease
June 18, 2004

Stem Cells, Development and Cancer
June 12, 2003

Invasion and Metastasis
June 21, 2002

The New Science of Cancer Therapy

June 24, 2005

Targeting the Hedgehog Pathway in Cancer

Philip A. Beachy, HHMI/ The Johns Hopkins University School of Medicine

Gleevec as a Paradigm of Targeted Cancer Therapies

Brian Drucker, HHMI/ Oregon Health & Science University Cancer Institute

Molecular Targeted Therapy of Lung Cancer

Daniel Haber, Massachusetts General Hospital

Targeted Therapy Becomes a Clinical Reality

Susan Hellmann, Genentech, Inc.

Targeted Therapy: from Bench to Bedside

Pearl Huang, GlaxoSmithKline

VHL Tumor Suppressor Protein: Insights into Oxygen Sensing and Kidney Cancer

William Kaelin, Dana-Farber Cancer Institute

Cancer Drug Delivery

Robert Langer, Massachusetts Institute of Technology

Therapeutic Targets in the Ras Pathway

Frank McCormick, USCF Comprehensive Cancer Center

Progress in the Development of Histone Deacetylase Inhibitors

Victoria Richon, Merck & Co., Inc.

How Did We Get Here?

Robert Weinberg, Whitehead Institute, MIT